Varda Space is launching a commercial mission to manufacture pharmaceutical compounds in microgravity, marking one of the first deals to develop medicine molecules in orbit and return them to Earth.
The partnership between Varda Space and United Therapeutics represents an early-stage effort to leverage the unique conditions of low Earth orbit for drug development. Microgravity environments enable the creation of drug molecules with properties difficult or impossible to achieve on the ground, potentially improving therapeutic effectiveness.
Varda CEO Will Bruey has signaled confidence in the commercial viability of orbital pharmaceutical manufacturing, suggesting additional missions may follow. The company plans to send medicines into space and retrieve them for further analysis and development.
While still in early phases, the deal signals growing interest from pharmaceutical companies in space-based research. Several firms have explored microgravity applications for protein crystals and drug formulations. Success could open a new market segment for commercial space ventures seeking revenue beyond satellite deployment and tourism.
The missions will test whether orbital manufacturing can deliver measurable advantages in drug efficacy, manufacturing efficiency, or cost—key factors determining whether space-based pharma production becomes economically viable at scale.
SolarSquare is in talks to raise up to $60 million in funding, with a potential valuation of $500 million. The financing round reflects growing venture capital interest in India's rooftop solar market.
College social app Fizz has expanded its lawsuit against competitor Sidechat, alleging that a Maveron venture capitalist shared confidential information obtained during a 2022 fundraising pitch with the rival startup.
Phia, a shopping app co-founded by Phoebe Gates, is allegedly using cookie stuffing—a fraudulent technique involving fake clicks—to claim unearned affiliate commissions. The startup has raised $43.5 million to date.
Toni Schneider has been promoted from interim to permanent CEO of Bluesky, four months after taking the role in March. Schneider, formerly CEO of Automattic, commits to leading the decentralized social platform.